In the case of CDK2, CCNE1 amplification is specifically over-represented among its associated exceptional responder cell lines (P = 8.215e-04; Table 2), consistent with the tumor type enrichment of ovarian cancer described above. This evidence concerns the gene CCNE1 and neoplasm.